However, the expression of TET2 was significantly downregulated relative to AML due to promoter hypermethylation, whereas DNMT1, DNMT3A, and DNMT3B were slightly upregulated by either demethylation or gained chromatin interactions. This evidence concerns the gene DNMT3A and acute myeloid leukemia.